Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Italian study checks accuracy of newborn screening for rare hormone disorder

NCT ID NCT06728748

First seen Apr 04, 2026 · Last updated May 22, 2026 · Updated 10 times

Summary

This study looked back at medical records of 29 newborns in Italy to see how well the standard newborn screening test detects congenital adrenal hyperplasia (CAH), a rare hormone condition. Researchers measured how many cases the screening caught and how accurate the test was. The goal was to understand the real-world impact of screening on early diagnosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGENITAL ADRENAL HYPERPLASIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Azienda Ospedaliera Città della Salute e della Scienza di Torino

    Torino, Torino, 10123, Italy

  • Azienda Ospedaliera Universitaria Integrata Verona:

    Verona, Verona, 37126, Italy

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    Bologna, Bologna, 40138, Italy

  • IRCCS Ospedale San Raffaele

    Milan, Milano, 20132, Italy

Conditions

Explore the condition pages connected to this study.